Assertio Therapeutics Inc (ASRT) Live Share Price, Invest From India

Assertio Therapeutics Inc Stock Performance

as on May 8, 2026 at 1:11 am IST

Day's Low
Day's High
$22.18
Day's Price Range
$22.50
$22.38
0.89%
Downside
0.54%
Upside
52 Week's Low
52 Week's High
$8.61
52-Week Price Range
$22.30
$22.38
61.53%
Downside
-0.36%
Upside

Assertio Therapeutics Inc share price movements today

Previous Close: $22.20
Open: $22.23
Volume: 68.3K
Day's Low - High: $22.18 - $22.50
52 Week Low - High: $8.61 - $22.30

Assertio Therapeutics Inc Historical Returns

1 Month Return: + 19.35 %
3 Month Return: + 74.25 %
1 Year Return: + 139.83 %
3 Year Return: -75.93 %
5 Year Return: -35.09 %

Assertio Therapeutics Inc Stock Fundamentals & Key Indicators

Check Assertio Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$143.0M

EPS (TTM)

-0.58

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.19%

PE Ratio (TTM)

PEG Ratio

1.5

EBITDA

12.8M

Revenue (TTM)

118.7M

Profit Margin

-25.59%

Return On Equity TTM

-28.25%

Assertio Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Assertio Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Assertio Therapeutics Inc	BUY	$143.0M	-35.09%	NA	-25.59%
United Therapeutics Corporation	BUY	$25.3B	NA	21.41	41.94%
Viatris Inc	HOLD	$18.1B	13.28%	NA	-24.58%
Haleon plc	BUY	$41.0B	NA	18.46	15.11%
Zoetis Inc	BUY	$46.9B	-35.17%	18.48	28.24%

Stock Returns calculator for Assertio Therapeutics Inc Stock including INR - Dollar returns

The Assertio Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Assertio Therapeutics Inc investment value today

Current value as on today

₹2,68,838

Returns

₹1,68,838

(+168.84%)

Returns from Assertio Therapeutics Inc Stock

₹1,41,685 (+141.68%)

Dollar Impact

₹27,153 (+27.15%)

Analyst Recommendation on Assertio Therapeutics Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Assertio Therapeutics Inc. Average target price of $23.87

Assertio Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Assertio Therapeutics Inc.

What analysts predicted

6.24%UPSIDE

Target Price

$23.87

Current Price

$22.38

Analyzed by

7 Analysts

Target

$23.87

Assertio Therapeutics Inc target price $23.87, a slight upside of 6.24% compared to current price of $22.38. According to 7 analysts rating.

Indian Investors' Interest in Assertio Therapeutics Inc Stock

Search interest for Assertio Therapeutics Inc Stock has increased by 256% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 7, 2026 to May 7, 2026

Change:256% versus previous 30 day period

Assertio Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	35	32	32	31	29	32	26	29	49	13
Gross Profit	28	23	21	22	21	20	18	18	35	10
Operating Income	-228	-32	-4	-3	-3	-13	-13	-8	11	-9
EBITDA	9	-1	2	3	4	-2	-3	-6	17	4
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	10	4	5	6	6	6	9	9	5	5
Income Before Tax	-228	-31	-4	-3	-2	-10	-13	-16	11	-11
Income Tax Expense	50	25	0	0	0	0	0	0	0	0
Net Income	-279	-57	-4	-3	-2	-10	-13	-16	11	-11
Net Profit Margin	-784.64%	-173.97%	-13.90%	-11.80%	-10.00%	-32.55%	-51.12%	-55.96%	23.14%	-81.65%

Assertio Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	455	380	311	229	108	111	156	152	124	118
Gross Profit	368	308	293	220	92	95	137	125	85	83
Operating Income	24	-42	43	-194	-82	9	39	-243	-24	-21
EBITDA	133	74	213	97	-16	38	90	53	5	12
Interest Expense	83	73	68	58	15	10	7	3	3	3
Depreciation	-	105	106	102	26	29	33	28	25	30
Income Before Tax	-64	-103	37	-211	-10	0	31	-254	-21	-29
Income Tax Expense	24	-1	1	5	17	0	-78	77	0	0
Net Income	-88	-102	36	-217	-28	-1	109	-331	-21	-29
Net Profit Margin	-19.46%	-26.92%	11.84%	-94.63%	-26.04%	-1.15%	70.17%	-218.28%	-17.27%	-24.85%

Assertio Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-57	-4	-3	-2	-10	-13	-16	11	-11
Operating Cash Flow	5	7	7	0	11	-12	19	-4	-29
Investing Cash Flow	0	-	-43	-6	1	-2	-6	-3	1
Financing Cash Flow	-8	0	0	0	0	0	0	0	0
Change in Cash	-3	7	-36	-6	12	-15	12	-8	-28

Assertio Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-102	36	-217	-28	-1	109	-331	-21	-30
Operating Cash Flow	62	72	90	-65	5	78	49	26	-28
Investing Cash Flow	57	-7	-1	512	-18	-42	3	-48	-11
Financing Cash Flow	-110	-81	-157	-468	29	-7	-44	0	0
Change in Cash	9	-15	-68	-21	16	28	8	-22	-40

Global Institutional Holdings in Assertio Therapeutics Inc

Funds	Holdings
Vanguard Group Inc	4.6%
Morgan Stanley - Brokerage Accounts	0.62%
Perritt Capital Management Inc.	0.36%
Opaleye Management Inc	4.42%
Northern Trust Corp	0.18%

See all

Insights on Assertio Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, ASRT has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 7 days, ASRT stock has moved up by 20.5%
NO EFFECT
Against Peers
In the last 3 years, United Therapeutics Corporation has given 178.7% return, outperforming this stock by 254.6%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 11.44M → -11.05M (in $), with an average decrease of 196.6% per quarter
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 49.45M → 13.54M (in $), with an average decrease of 72.6% per quarter

About Assertio Therapeutics Inc

Assertio Holdings, Inc., a pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA, a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain, nausea, photophobia, and phonophobia; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; and ROLVEDON, a long-acting granulocyte colony-stimulating factor that is indicated to decrease the incidence of infection caused by febrile neutropenia. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 2020 and is headquartered in Lake Forest, Illinois.

Organisation	Assertio Therapeutics Inc
Headquarters	100 South Saunders Road, Lake Forest, IL, United States, 60045
Industry	Drug Manufacturers - Specialty & Generic
CEO	Mr. Mark L. Reisenauer
E-voting on shares	Click here to vote

Key Management of Assertio Therapeutics Inc

Name	Title
Mr. Mark L. Reisenauer	CEO & Director
Mr. Paul Schwichtenberg	President & COO
Mr. Ajay Patel	Executive VP & CFO
Mr. Sam Schlessinger	Executive VP & General Counsel
Dr. Howard J. Franklin M.B.A., M.D.	Senior Vice President of Medical

FAQs

What is Assertio Therapeutics Inc share price today?

Assertio Therapeutics Inc share price today is $22.38 as on May 7, 2026 at 7:41 pm IST. Assertio Therapeutics Inc share today touched a day high of $22.5 and a low of $22.18.

What is the 52 week high and 52 week low for Assertio Therapeutics Inc share?

Assertio Therapeutics Inc share touched a 52 week high of $22.3 on May 5, 2026 and a 52 week low of $8.61 on December 31, 2025. Assertio Therapeutics Inc stock price today i.e. May 7, 2026 at 7:41 pm IST is trending at $22.38,which is -0.36% down from its 52 week high and 159.93% up from its 52 week low.

What is Assertio Therapeutics Inc's market capitalisation today?

Assertio Therapeutics Inc market capitalisation is $0.00T as on May 7, 2026 at 7:41 pm IST.

How to invest in Assertio Therapeutics Inc Stock (ASRT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Assertio Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Assertio Therapeutics Inc Shares that will get you 0.0670 shares as per Assertio Therapeutics Inc share price of $22.38 per share as on May 7, 2026 at 7:41 pm IST.

What is the minimum amount required to buy Assertio Therapeutics Inc Stock (ASRT) from India?

Indian investors can start investing in Assertio Therapeutics Inc (ASRT) shares with as little as ₹94.24 or $1 (as of May 7, 2026 at 7:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹942.40 in Assertio Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on May 7, 2026 at 7:41 pm IST). Based on Assertio Therapeutics Inc share’s latest price of $22.38 as on May 7, 2026 at 7:41 pm IST, you will get 0.4468 shares of Assertio Therapeutics Inc. Learn more about fractional shares .

What are the returns that Assertio Therapeutics Inc has given to Indian investors in the last 5 years?

Assertio Therapeutics Inc stock has given -35.09% share price returns and 29.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?